Chapter 25. Immunosuppressive Therapy to Counter Cardiac Allograft Vasculopathy

  1. Ronald Ross Watson1,2 and
  2. Douglas F. Larson3
  1. Carl V. Leier

Published Online: 15 APR 2008

DOI: 10.1002/9780470692325.ch25

Immune Dysfunction and Immunotherapy in Heart Disease

Immune Dysfunction and Immunotherapy in Heart Disease

How to Cite

Leier, C. V. (2007) Immunosuppressive Therapy to Counter Cardiac Allograft Vasculopathy, in Immune Dysfunction and Immunotherapy in Heart Disease (eds R. R. Watson and D. F. Larson), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470692325.ch25

Editor Information

  1. 1

    Department of Nutritional Sciences, The University of Arizona; and Sarver Heart Center, College of Medicine, The University of Arizona

  2. 2

    Division of Health Promotion Sciences, Mel and Enid Zuckerman Arizona College of Public Health, The University of Arizona Tucson, AZ USA

  3. 3

    Sarver Heart Center College of Medicine The University of Arizona Tucson, AZ USA

Publication History

  1. Published Online: 15 APR 2008
  2. Published Print: 30 AUG 2007

ISBN Information

Print ISBN: 9781405155687

Online ISBN: 9780470692325

SEARCH

Keywords:

  • immunosuppressive therary;
  • cardiac allograft;
  • vasculopathy;
  • pathogenic process;
  • induction therapy

Summary

This chapter contains section titled:

  • Overview

  • Cardiac allograft vasculopathy: general concepts

  • Cardiac allograft vasculopathy: management approach

  • Closing comments

  • References